Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...
The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback